Not Yet Recruiting
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
NCT06502171
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States